Myriad Genetics announced the appointment of Jennifer Fox as Chief Legal Officer, effective September 3, 2024. As Chief Legal Officer, Fox’s responsibilities will encompass a wide range of areas, including support and counsel for all legal affairs, intellectual property, patent protection, mergers and acquisitions, litigation, regulatory and quality assurance, compliance, privacy, and government affairs. Fox most recently served as the Executive Vice President of External Affairs for Emergent BioSolutions where she was responsible for overseeing legal functions, government and public affairs, communications, and ESG initiatives.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MYGN:
- MYGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Myriad Genetics announces results from nationwide Cancer Risk Survey
- What We Don’t Know Can Hurt: New Cancer Risk Survey from Myriad Genetics Reveals Serious Knowledge Gaps About Breast Density and Cancer Risk
- Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing
- Myriad Genetics, Personalis enter agreement to cross-license patent estates